轻度子宫内膜异位症IVF前超长GnRH-a方案改善受精率但不提高临床妊娠率
结果显示GnRH-a组卵泡液中TNF-α、IL-1β、IL-6、IL-8及IL-1受体拮抗剂浓度显著降低,受精率高于B组(72.7 vs 61.7),但胚胎质量、着床率和临床妊娠率无显著改善。
要点
- IVF前使用3个月GnRH-a可显著降低轻度内异症患者卵泡液炎性细胞因子浓度。
- GnRH-a组受精率72.7%(95%CI 70.50-74.90),高于不用GnRH-a组的61.7%(95%CI 59.20-64.20)。
- 两组胚胎质量、着床率和临床妊娠率无统计学显著差异。
核心结论
- 轻度子宫内膜异位症患者IVF前使用3个月GnRH-a可降低卵泡液细胞因子浓度并提高受精率,但着床率、胚胎质量和临床妊娠率无显著改善。
研究设计与样本
- 前瞻性随机对照试验,在3家三级大学医院开展。
- 另纳入200例输卵管因素不孕女性作为参照。
主要发现
- GnRH-a组卵泡液中TNF-α、IL-1β、IL-6、IL-8及IL-1受体拮抗剂浓度较不用GnRH-a组显著降低。
- B组受精率61.7%(95%CI 59.20-64.20),低于A组的72.7%(95%CI 70.50-74.90),也低于输卵管因素不孕组的74.7%(95%CI 72.00-77.24)。
- A组与B组在胚胎质量、着床率和临床妊娠率方面无统计学显著差异。
关键数值与推荐
- GnRH-a用法:IVF前使用3个月。
- 受精率:A组72.7%(95%CI 70.50-74.90),B组61.7%(95%CI 59.20-64.20),输卵管因素组74.7%(95%CI 72.00-77.24)。
临床怎么用
- 对轻度子宫内膜异位症不孕患者,IVF前使用3个月GnRH-a可能通过降低卵泡液炎性细胞因子改善受精率。
- 该方案未显示能提高胚胎质量、着床率或临床妊娠率,临床决策需综合权衡。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the effects of gonadotropin-releasing hormone agonists (GnRH-a) on fertility in women with mild endometriosis who are undergoing in vitro fertilization and embryo transfer (IVF-ET) procedures. DESIGN: Prospective, randomized, controlled trial. SETTING: Three tertiary university hospitals. PATIENT(S): Four hundred infertile women with mild endometriosis, documented with laparoscopy, undergoing IVF and 200 women with tubal factor infertility. INTERVENTION(S): Administration of GnRH-a for 3 months before an IVF attempt (group A, n = 200) or IVF without GnRH-a (group B, n = 200). MAIN OUTCOME MEASURE(S): Follicular fluid (FF) levels of tumor necrosis factor α (TNF-α), interleukin-1β (IL-1β), IL-6, IL-8, and IL-1 receptor antagonist; fertilization rate (FR), implantation rate (IR), quality of embryos, and clinical pregnancy rate (PR). RESULT(S): Women who received GnRH-a had a statistically significantly reduced concentration of FF cytokines compared with women who did not receive this regimen. Women in group B had a reduced FR (61.7; 95% CI, 59.20-64.20) compared with the women in group A (72.7; 95% CI, 70.50-74.90) and compared with the women with tubal factor infertility (74.7; 95% CI, 72.00-77.24). The embryo quality, IR, and clinical PR showed no statistically significant improvement in the women of group A compared with group B. CONCLUSION(S): Women who received GnRH-a for 3 months had a lower concentration of FF cytokines. These women had also a higher FR than the women who did not receive GnRH-a. However, the IR, embryo quality, and clinical PR showed no statistically significant difference when comparing the two groups. CLINICALTRIALS. GOV ID: NCT01269125.
引用
- Kaponis A, Chatzopoulos G, Paschopoulos M, et al. Ultralong administration of gonadotropin-releasing hormone agonists before in vitro fertilization improves fertilization rate but not clinical pregnancy rate in women with mild endometriosis: a prospective, randomized, controlled trial. Fertil Steril. 2020. PMID: 32147182. doi:10.1016/j.fertnstert.2019.12.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。